Cargando…

Investigation the determinants of pharmaceutical expenditure share of GDP in Iran and selected OECD countries

AIM: This study estimated the GDP share of pharmaceuticals in Iran based on the drivers of pharmaceutical expenditure and compared it with that of 31 members of the Organisation for Economic Cooperation and Development (OECD). SUBJECT AND METHODS: The factors contributing to pharmaceutical expenditu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kadkhodamanesh, Azin, Varahrami, Vida, Zarei, Leila, Peiravian, Farzad, Hadidi, Mohammad, Yousefi, Nazila
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513196/ https://www.ncbi.nlm.nih.gov/pubmed/34641978 http://dx.doi.org/10.1186/s40545-021-00371-2

Ejemplares similares

Catastrophic pharmaceutical expenditure in patients with type 2 diabetes in Iran
por: Zarei, Leila, et al.
Publicado: (2022)

Impact of the Trade-Related Aspect of Intellectual Property Rights Agreement on Pharmaceutical Industry in Developing Countries: A Scoping Review
por: Fathi, Mahdieh, et al.
Publicado: (2021)

Generation mix and GDP growth in OECD countries
por: Harnphattananusorn, Supanee, et al.
Publicado: (2022)

Bootstrap ARDL on Health Expenditure, CO2 Emissions, and GDP Growth Relationship for 18 OECD Countries
por: Wang, Chien-Ming, et al.
Publicado: (2019)

How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?
por: Shobeiri, Nikta, et al.
Publicado: (2022)

How does external reference pricing work in developing countries: evidence from Iran
por: Babaie, Fatemeh, et al.
Publicado: (2023)

Public and decision-maker stated preferences for pharmaceutical subsidy decisions in Iran: an application of the discrete choice experiment
por: Afsharmanesh, Gita, et al.
Publicado: (2021)

An investigation into the pharmaceutical advertising in Iranian medical journals
por: Yousefi, Nazila, et al.
Publicado: (2022)

Country Pharmaceutical Situation on Access, Quality, and Rational Use of Medicines: An Evidence from a middle-income country
por: Minaei, Hossein, et al.
Publicado: (2019)

Do countries with higher GDP spend more on disabilities? New evidence in OECD countries
por: Karami Matin, Behzad, et al.
Publicado: (2019)

Convergence and determinants of health expenditures in OECD countries
por: Nghiem, Son Hong, et al.
Publicado: (2017)

An application of analytic network process model in supporting decision making to address pharmaceutical shortage
por: Zarei, Leila, et al.
Publicado: (2020)

Health Expenditure Trends in OECD Countries, 1970-1997
por: Huber, Manfred
Publicado: (1999)

Health Expenditure Trends in OECD Countries, 1990-2001
por: Huber, Manfred, et al.
Publicado: (2003)

Globalisation, Welfare Models and Social Expenditure in OECD Countries
por: Santos, Marcelo, et al.
Publicado: (2021)

Evaluating the affordability of asthma, chronic obstructive pulmonary disease, and cystic fibrosis medicines in a middle-income country
por: Fathi, Mahdieh, et al.
Publicado: (2023)

The Scarce Drugs Allocation Indicators in Iran: A Fuzzy Delphi Method Based Consensus
por: Zarei, Leila, et al.
Publicado: (2019)

Determinants of health expenditure in OECD countries: A decision tree model
por: Akca, Nesrin, et al.
Publicado: (2017)

Editorial: Economic growth and health expenditures relationship between OECD countries
por: Tengilimoğlu, Dilaver
Publicado: (2023)

The Effect of Organizational Resilience and Strategic Foresight on Firm Performance: Competitive Advantage as Mediating Variable
por: Fathi, Mahdieh, et al.
Publicado: (2021)

Exploring health seeking behaviors for common cold management
por: Keshvari, Negin, et al.
Publicado: (2023)

Adjusting health expenditure for military spending and interest payment: Israel and the OECD countries
por: Shmueli, Amir, et al.
Publicado: (2013)

Government health expenditures and health outcome nexus: a study on OECD countries
por: Anwar, Asim, et al.
Publicado: (2023)

Teriparatide in the Treatment of Severe Postmenopausal Osteoporosis: A Cost-Utility Analysis
por: Taheri, Saeed, et al.
Publicado: (2019)

Purchasing power parities and real expenditures in the OECD
por: Ward, Michael
Publicado: (1985)

More Health Expenditure, Better Economic Performance? Empirical Evidence From OECD Countries
por: Wang, Fuhmei
Publicado: (2015)

How Much Iranian Parents Know of and How Well They Practice Regarding Antibiotics?
por: Sharif, Zahra, et al.
Publicado: (2021)

3rd Ministerial Meeting on Science of OECD Countries - Gaps in Technology : Pharmaceuticals
por: Organisation for Economic Cooperation and Development. Paris
Publicado: (1968)

An application of multi-criteria decision-making approach to sustainable drug shortages management: evidence from a developing country
por: Moosivand, Asiye, et al.
Publicado: (2021)

Health Care Expenditure and GDP in African Countries: Evidence from Semiparametric Estimation with Panel Data
por: Lv, Zhike, et al.
Publicado: (2014)

The impact of public health expenditure and gross domestic product per capita on the risk of catastrophic health expenditures for OECD countries
por: Söyük, Selma
Publicado: (2023)

Health Care Expenditure and GDP in Oil Exporting Countries: Evidence from OPEC Data, 1995-2012
por: Fazaeli, Ali Akbar, et al.
Publicado: (2016)

Predictors of (in)efficiencies of Healthcare Expenditure Among the Leading Asian Economies – Comparison of OECD and Non-OECD Nations
por: Jakovljevic, Mihajlo, et al.
Publicado: (2020)

Attributes Development for Pharmaceutical Subsidization: A Qualitative Study
por: Afsharmanesh, Gita, et al.
Publicado: (2020)

Efficacy and Safety of Dulaglutide Compared to Liraglutide: A Systematic Review and Meta-analysis in Patients with Type 2 Diabetes Mellitus
por: Taheri, Saeed, et al.
Publicado: (2019)

The impact of rural health insurance and the family physician program on hospitalizations, a beforeafter study at the county level conducted in Tehran province, Iran
por: Salavati, Sedigheh, et al.
Publicado: (2018)

Nonlinear Granger Causality between Health Care Expenditure and Economic Growth in the OECD and Major Developing Countries
por: Ye, Liping, et al.
Publicado: (2018)

The relationship between health expenditure indicators and economic growth in OECD countries: A Driscoll-Kraay approach
por: Beylik, Umut, et al.
Publicado: (2022)

Review of fisheries in OECD countries
Publicado: (1995)

Environmental taxes in OECD countries.
Publicado: (1996)

Cannot write session to /tmp/vufind_sessions/sess_p93u1fvntpuvu8a6rs5grbd7hl